Ventilator Associated Pneumonia. Pneumonitis due to other solids and liquids
Conditions
Interventions
Intervention 1: The first group 5 ml chlorhexidine 0.2% product of Behsa pharmaceutical company which will be produced to mucoadhesive form by the School of Pharmacy of Zanjan University of Medical Sc
Treatment - Drugs
The first group 5 ml chlorhexidine 0.2% product of Behsa pharmaceutical company which will be produced to mucoadhesive form by the School of Pharmacy of Zanjan University of Medical Sciences as mouthw
The control group 5 ml oral solution containing chlorhexidine %0.2 product of Behsa pharmaceutical company as mouthwash will be received three times a day
Sponsors
Vice- Chancellor for Research of Zanjan University
Eligibility
Sex/Gender
All
Age
20 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Age between 20 and 50 years, Intubated patients and under mechanical ventilation, patients who have tooth, patients who are not pregnant, patients who have not Tracheostomy or T tube, Do not feeding from jejunostomy, don't have parental feeding. exclusion criteria: Admission less than one week, Death in less than 7 days after intubation,Extubation in less than 7 days
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ventilator Associated Pneumonia. Timepoint: Third day, Sixth day, Ninth day, The twelfth day. Method of measurement: Clinical Pulmonary Infection Score. | — |
Secondary
| Measure | Time frame |
|---|---|
| Connection to ventilator days. Timepoint: End of the study. Method of measurement: Records.;Length of Intensive Care Unit stay. Timepoint: End of the study. Method of measurement: Records.;Mortality during hospitalization in Intensive Care Unit. Timepoint: End of the study. Method of measurement: Records. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAli Zargar
Zanjan University of Medical Sciences
Outcome results
None listed